S&P Global [SPGI] vs CME [CME] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: S&P Global wins in 7 metrics, CME wins in 13 metrics, with 0 ties. CME appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricS&P GlobalCMEBetter
P/E Ratio (TTM)36.6426.17CME
Price-to-Book Ratio4.363.45CME
Debt-to-Equity Ratio31.6513.60CME
PEG Ratio4.381.67CME
EV/EBITDA22.0721.44CME
Profit Margin (TTM)27.29%58.59%CME
Operating Margin (TTM)42.69%66.87%CME
EBITDA Margin (TTM)42.69%66.87%CME
Return on Equity11.29%13.61%CME
Return on Assets (TTM)6.26%1.74%S&P Global
Free Cash Flow (TTM)$5.57B$3.60BS&P Global
Dividend Yield0.55%4.30%CME
1-Year Return-6.32%17.93%CME
Price-to-Sales Ratio (TTM)9.9015.14S&P Global
Enterprise Value$160.25B$97.48BS&P Global
EV/Revenue Ratio10.9015.15S&P Global
Gross Profit Margin (TTM)70.20%86.90%CME
Revenue per Share (TTM)$48$18S&P Global
Earnings per Share (Diluted)$13.01$10.16S&P Global
Beta (Stock Volatility)1.190.43CME
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

S&P Global vs CME Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
S&P Global0.67%-1.51%-11.02%-9.40%-1.96%-3.17%
CME-0.29%-2.08%-1.74%-4.35%-1.38%13.73%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
S&P Global-6.32%57.56%34.49%434.67%1,297.64%920.00%
CME17.93%55.76%56.23%199.74%404.33%294.38%

News Based Sentiment: S&P Global vs CME

S&P Global

News based Sentiment: POSITIVE

October saw S&P Global receive positive analyst attention, expand its business through acquisition, and launch a new ESG platform, while also navigating a projected revenue decrease and experiencing mixed credit rating activity across different entities. The overall narrative suggests a company focused on strategic growth and profitability despite some headwinds.

View S&P Global News Sentiment Analysis

CME

News based Sentiment: POSITIVE

CME Group is demonstrating strong financial performance and strategic growth, particularly in the rapidly expanding cryptocurrency market. The upcoming earnings report and new product launches represent key catalysts for continued positive momentum, despite some mixed signals from institutional investors.

View CME News Sentiment Analysis

Performance & Financial Health Analysis: S&P Global vs CME

MetricSPGICME
Market Information
Market Cap i$149.43B$96.97B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,139,1401,918,300
90 Day Avg. Volume i1,457,9231,895,850
Last Close$479.81$264.67
52 Week Range$427.14 - $579.05$213.94 - $290.79
% from 52W High-17.14%-8.98%
All-Time High$579.05 (Aug 14, 2025)$290.79 (Jun 02, 2025)
% from All-Time High-17.14%-8.98%
Growth Metrics
Quarterly Revenue Growth0.06%0.10%
Quarterly Earnings Growth0.06%0.16%
Financial Health
Profit Margin (TTM) i0.27%0.59%
Operating Margin (TTM) i0.43%0.67%
Return on Equity (TTM) i0.11%0.14%
Debt to Equity (MRQ) i31.6513.60
Cash & Liquidity
Book Value per Share (MRQ)$109.37$77.13
Cash per Share (MRQ)$6.05$5.82
Operating Cash Flow (TTM) i$5.58B$4.20B
Levered Free Cash Flow (TTM) i$4.93B$2.92B
Dividends
Last 12-Month Dividend Yield i0.55%4.30%
Last 12-Month Dividend i$2.78$11.85

Valuation & Enterprise Metrics Analysis: S&P Global vs CME

MetricSPGICME
Price Ratios
P/E Ratio (TTM) i36.6426.17
Forward P/E i28.3525.64
PEG Ratio i4.381.67
Price to Sales (TTM) i9.9015.14
Price to Book (MRQ) i4.363.45
Market Capitalization
Market Capitalization i$149.43B$96.97B
Enterprise Value i$160.25B$97.48B
Enterprise Value Metrics
Enterprise to Revenue i10.9015.15
Enterprise to EBITDA i22.0721.44
Risk & Other Metrics
Beta i1.190.43
Book Value per Share (MRQ) i$109.37$77.13

Financial Statements Comparison: S&P Global vs CME

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SPGICME
Revenue/Sales i$3.78B$1.64B
Cost of Goods Sold i$1.15B$206.70M
Gross Profit i$2.62B$1.44B
Research & Development iN/AN/A
Operating Income (EBIT) i$1.57B$1.11B
EBITDA i$1.88B$476.30M
Pre-Tax Income i$1.50B$1.24B
Income Tax i$325.00M$288.60M
Net Income (Profit) i$1.17B$956.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SPGICME
Cash & Equivalents i$1.47B$1.41B
Total Current Assets i$5.34B$123.45B
Total Current Liabilities i$5.92B$121.42B
Long-Term Debt i$11.91B$3.42B
Total Shareholders Equity i$37.73B$27.03B
Retained Earnings i$21.80B$4.69B
Property, Plant & Equipment i$1.50B$371.20M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SPGICME
Operating Cash Flow i$708.00M$838.30M
Capital Expenditures iN/A$-14.20M
Free Cash Flow i$910.00M$1.10B
Debt Repayment i$-4.00M$-750.00M
Common Stock Repurchase i$-650.00MN/A

Short Interest & Institutional Ownership Analysis

MetricSPGICME
Shares Short i3.34M4.63M
Short Ratio i3.212.42
Short % of Float i0.01%0.01%
Average Daily Volume (10 Day) i2,139,1401,918,300
Average Daily Volume (90 Day) i1,457,9231,895,850
Shares Outstanding i307.80M359.61M
Float Shares i304.63M358.74M
% Held by Insiders i0.00%0.00%
% Held by Institutions i0.90%0.92%

Dividend Analysis & Yield Comparison: S&P Global vs CME

MetricSPGICME
Last 12-Month Dividend i$2.78$11.85
Last 12-Month Dividend Yield i0.55%4.30%
3-Year Avg Annual Dividend i$3.00$10.10
3-Year Avg Dividend Yield i0.21%0.91%
3-Year Total Dividends i$9.00$30.30
Ex-Dividend DateFeb 26, 2025Sep 09, 2025